Benjamin Baker

Human Malignant Melanomas Express Receptors for Luteinizing Hormone Releasing Hormone Allowing Targeted Therapy with Cytotoxic Luteinizing Hormone Releasing Hormone Analogue

Gunhild Keller, Andrew V. Schally, Timo Gaiser et al. · Cancer Research · 2005 · 41 citations · Full text

Medicine, Oncology, Pharmacology +17

Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormone-releasing hormone and their combinations

Stefan Buchholz, Gunhild Keller, Andrew V. Schally et al. · Proceedings of the National Academy of Sciences · 2006 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17

Inhibition of human androgen-independent PC-3 and DU-145 prostate cancers by antagonists of bombesin and growth hormone releasing hormone is linked to PKC, MAPK and c-jun intracellular signalling

Anton Stangelberger, Andrew V. Schally, József L. Varga et al. · European Journal of Cancer · 2005 · 37 citations

Medicine, Oncology, Pharmacology +10

Dominant-negative mutant thyroid hormone receptors prevent transcription from Xenopus thyroid hormone receptor beta gene promoter in response to thyroid hormone in Xenopus tadpoles in vivo.

Salvatore Ulisse, G Esslemont, Benjamin Baker et al. · Proceedings of the National Academy of Sciences · 1996 · 35 citations

Life Sciences, Genetics, Molecular Biology +16

Targeted cytotoxic bombesin analog AN-215 effectively inhibits experimental human breast cancers with a low induction of multi-drug resistance proteins

J. Engel, Andrew V. Schally, Gábor Halmos et al. · Endocrine Related Cancer · 2005 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17